IGHD5OR15-5B

Q-omics provides the consensus-scored IGHD5OR15-5B profile across patient tissues and cancer cell-line models. IGHD5OR15-5B expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, IGHD5OR15-5B RNA expression shows 3,999 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where IGHD5OR15-5B shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes IGHD5OR15-5B survival associations across molecular data types. IGHD5OR15-5B RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

IGHD5OR15-5B data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	STAD (63)	view →

This table ranks reproducible IGHD5OR15-5B RNA expression–survival associations across cancer types. High IGHD5OR15-5B expression shows unfavorable associations in STAD. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for IGHD5OR15-5B RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.149	0.710	<.001	63	view →

Pink = unfavorable, green = favorable. all 1 lineages →

IGHD5OR15-5B-STAD (DFS)

Explore this curve interactively →